David McClung
Net Worth

Last updated:

What is David McClung net worth?

The estimated net worth of Mr. David McClung is at least $2,373,301 as of 10 Oct 2022. He owns shares worth $149,051 as insider and has received compensation worth at least $2,224,250 in BioCardia, Inc..

What is the salary of David McClung?

Mr. David McClung salary is $317,750 per year as Chief Financial Officer in BioCardia, Inc..

How old is David McClung?

Mr. David McClung is 62 years old, born in 1963.

What stocks does David McClung currently own?

As insider, Mr. David McClung owns shares in one company:

Company Title Shares Price per share Total value
BioCardia, Inc. (BCDA) Chief Financial Officer 78,518 $1.9 $149,051

What does BioCardia, Inc. do?

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.

David McClung insider trading

BioCardia, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 2,000 $2.07 $4,140
Purchase
Warrant (right to buy) 16,871 $8 $134,968
Purchase
Common Stock 1,600 $2.56 $4,102
Purchase
Common Stock 500 $2.64 $1,318
Purchase
Common Stock 2,850 $2.45 $6,988
Purchase
Common Stock 500 $1.9 $950
Purchase
Common Stock 750 $1.9 $1,425

BioCardia key executives

BioCardia, Inc. executives and other stock owners filed with the SEC: